Moderna on Wednesday reported second quarter results that beat earnings and revenue expectations driven $4.5 billion in sales from its COVID -19 vaccine, but it's still the company's only commercially available product and it took a big hit on expiring shots.
Monthly Medicare premiums for "Part D" prescription drug coverage are projected to be $31.50 in 2023, down 1.8% from $32.08 this year, the Biden administration announced Friday.
California lawmakers set aside $100 million in the recently adopted 2022-23 state budget to help launch the CalRx drug label, and the state could start producing generic insulin within the next few years.
The pharmaceutical industry, notorious for its deep pockets and aggressive lobbying tactics, has a nearly spotless record dominating policy fights. Now, the sector is staring down its biggest test in at least a decade.